publication date: May. 13, 2016

NIH Makes Sweeping Changes In Clinical Center Governance 

 

The NIH Clinical Center will be placed under a new system of governance, similar to that of hospitals.

Replacing Director John Gallin and the current management structure, NIH has begun “the process of changing the leadership structure of the Clinical Center to model those of world class hospitals in the United States,” institute officials said in a statement.

“NIH will begin a nationwide search for a physician CEO with proven experience in management of a complex inpatient and outpatient facility,” the statement reads. “This individual will be ultimately responsible for oversight of all facilities and will report quarterly to the new Hospital Board, providing metrics about hospital performance and regulatory compliance.”

Gallin, who has served as director of the clinical center for the past 22 years, will remain at the center for the near future, implementing the recommendations of a report by an outside group.

Gallin and his team “will continue their leadership of the Clinical Center, including working to implement the Red Team recommendations,” the NIH statement reads. “NIH is deeply grateful to Dr. Gallin and his colleagues for their dedicated leadership, and will count on them over the next few months to move this effort forward with maximum energy and intensity.”

The working group’s report said that “failing to take appropriate steps to minimize [research] risks is a disservice to both the patients and the quality of the research itself” and found “substantial operations issues,” including:

• … Continue reading 42-19 NIH Makes Sweeping Changes In Clinical Center Governance

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.